PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons.
Website URL : http://www.pharmathene.com
Stock Ticker : PIP
PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene’s lead product development programs include: SparVax(TM) a second generation recombinant protective antigen (rPA) anthrax vaccine, Third generation rPA anthrax vaccine, Valortim(R) a fully human monoclonal antibody for the prevention and treatment of anthrax infection, and Protexia(R) a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents.
© Copyright 2012. HealthcareFirms.com | Heathcare Company Web Directory - Theme by DirectoryPress 2.10 - Developed By Mark Fail Site Map | Terms & Conditions | Privacy Policy